This topic contains a solution. Click here to go to the answer

Author Question: What is the intended response to an erythropoiesis-stimulating agent (ESA)? a. Increased red ... (Read 80 times)

WWatsford

  • Hero Member
  • *****
  • Posts: 539
    • Biology Forums!
What is the intended response to an erythropoiesis-stimulating agent (ESA)?
 
  a. Increased red blood cell counts
  b. Decreased red blood cell counts
  c. Increased platelet counts
  d. Decreased platelet counts

Question 2

What health problem is a possible side effect of erythropoiesis-stimulating agent (ESA) therapy?
 
  a. Increased risk for infection
  b. Low blood pressure
  c. Hypertension
  d. Anemia



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

asdfasdf

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

ANS: A

Answer to Question 2

ANS: C




WWatsford

  • Member
  • Posts: 539
Reply 2 on: Jul 24, 2018
Great answer, keep it coming :)


hollysheppard095

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Only one in 10 cancer deaths is caused by the primary tumor. The vast majority of cancer mortality is caused by cells breaking away from the main tumor and metastasizing to other parts of the body, such as the brain, bones, or liver.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

Hypertension is a silent killer because it is deadly and has no significant early symptoms. The danger from hypertension is the extra load on the heart, which can lead to hypertensive heart disease and kidney damage. This occurs without any major symptoms until the high blood pressure becomes extreme. Regular blood pressure checks are an important method of catching hypertension before it can kill you.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

For a complete list of videos, visit our video library